LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Low Folate Levels Can Indicate Malnutrition in Hospital Patients

By LabMedica International staff writers
Posted on 04 Mar 2020
Image: Serum folate and B vitamins should be tested in certain patients than are being hospitalized (Photo courtesy of Toliopoulos Diagnostics/Roche).
Image: Serum folate and B vitamins should be tested in certain patients than are being hospitalized (Photo courtesy of Toliopoulos Diagnostics/Roche).
Folate deficiency, also known as vitamin B9 deficiency, is a low level of folate and derivatives in the body. Signs of folate deficiency are often subtle. A low number of red blood cells (anemia) are a late finding in folate deficiency and folate deficiency anemia is the term given for this medical condition.

About 10% of patients who come to complex care hospitals may have low levels of folate and other indicators of malnutrition. To ensure those patients are identified and helped, those who present with gastrointestinal problems, chronic kidney disease or sepsis, all associated with malnutrition, need to have their folate levels tested on admission.

Scientists at the Medical College of Georgia (Augusta, GA, USA) reviewed the medical records of 1,019 patients with serum folate less than 7.0 ng/mL, 301 patients with serum folate of 15 ng/mL, and 300 patients with serum folate more than 23 ng/mL.

The investigators reported that serum pre-albumin levels were subnormal in 54.8% of patients with serum folate less than 7.0 ng/mL. Vitamin B12, hemoglobin, and serum albumin levels were significantly lower in the less than 7.0 ng/mL folate group. One or more markers of malnutrition were present in 62.4% of patients with serum folate less than 7.0 ng/mL. The low-folate group had a significantly higher prevalence of gastrointestinal (GI) disorders, sepsis, and abnormal serum creatinine level. There were no significant differences in the two groups regarding diabetes; behavioral/neurological disorders, including drug and alcohol abuse; bariatric surgery; or a diagnosis of malnutrition.

A complicating factor was that as many as 60% of the patients the team reviewed had received a folic acid supplement before they were tested, which meant that low folate levels could be even more prevalent. That finding and other indicators of nutritional deficiency prompted the AU Health System to urge medical staff to do folic acid testing before any supplements or blood products were given, even before patients eat a hospital meal. The health system's Medical Executive Board also approved automatic testing for prealbumin and B12 in those found to have a folate level of less than 7ng/mL.

Gurmukh Singh, MD, PhD, MBA, vice chair of pathology and senior author of the study, said, “We looked at people who had low levels and relatively normal folate levels. The people with low levels had a higher incidence of gastrointestinal disorders like chronic diarrhea as well as sepsis and kidney disease. The other piece was that people who had low levels also had other markers of malnutrition.”

The authors concluded that the prevalence of folate deficiency depends on what is considered a normal serum folate level. Approximately 10% of tertiary-care patients have level less than 7.0 ng/mL and exhibit other markers of malnutrition. It is recommended that patients with GI disorders, chronic kidney disease, and sepsis be routinely tested for serum folate levels, before administration of vitamin supplements. Patients with serum folate levels less than 7.0 ng/mL should be evaluated for malnutrition and Folate supplementation should be administered only after excluding coexisting vitamin B12 deficiency. The study was published on Januarys 30, 2020 in the Laboratory Medicine.

Related Links:
Medical College of Georgia

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more